A phase I trial of ABI-007, nanoparticle paclitaxel, administered to patients with advanced non-hematologic malignancies.
暂无分享,去创建一个
D. V. Von Hoff | E. Hersh | N. Desai | V. Trieu | D. Nyman | K. Campbell | K. Richardson | K. Patrick
暂无分享,去创建一个
D. V. Von Hoff | E. Hersh | N. Desai | V. Trieu | D. Nyman | K. Campbell | K. Richardson | K. Patrick